Evidence map›Paper›PMID 22686734›Full record

ArticleBritish journal of clinical pharmacology2013

Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.

John Coutsouvelis, Meredith Wiseman, Lisa Hui, Susan Poole, Michael Dooley, Sushrut Patil, Sharon Avery, Andrew Wei, Andrew Spencer

Abstract readLetter
In one paragraph

Article in British journal of clinical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Tumour lysis syndrome.Nature reviews. Disease primers · 2024
    Review
  3. Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2018
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John Coutsouvelis
Meredith Wiseman
Lisa Hui
Susan Poole
Michael Dooley
Sushrut Patil
Sharon Avery
Andrew Wei
Andrew Spencer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overDose-Response Relationship, DrugFemaleGout SuppressantsHumansMaleMiddle AgedTreatment OutcomeTumor Lysis SyndromeUrate OxidaseYoung AdultGout SuppressantsrasburicaseUrate Oxidase

Identifiers

PMID22686734
PMCPMC3579269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.